Combined effects of niclosamide and temozolomide against human glioblastoma tumorspheres

PURPOSE: Glioblastoma (GBM) is the most aggressive type of brain tumor and has poor survival outcomes, even after a combination of surgery, radiotherapy, and chemotherapy. Temozolomide is the only agent that has been shown to be effective against GBM, suggesting that combination of temozolomide with...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Cancer Res Clin Oncol
Egile Nagusiak: Oh, Hyeong-Cheol, Shim, Jin-Kyoung, Park, Junseong, Lee, Ji-Hyun, Choi, Ran Joo, Kim, Nam Hee, Kim, Hyun Sil, Moon, Ju Hyung, Kim, Eui Hyun, Chang, Jong Hee, Yook, Jong In, Kang, Seok-Gu
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Springer Berlin Heidelberg 2020
Gaiak:
Original Article – Cancer Research
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7519913/
https://ncbi.nlm.nih.gov/pubmed/32712753
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00432-020-03330-7
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak